1 Mercadante S . Malignant bone pain: pathophysiology and treatment . Pain1997; 69: 1 – 18 .
2.
2 Portenoy RK Payne D Jacobsen P . Breakthrough pain: characteristics and impact in patients with cancer pain . Pain1999; 81: 129 – 134 .
3.
3 Janjan NA Payne R Gillis T Podoloff D Libshitz HI Lenzi R . Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases . J Pain Symptom Manage1998; 16: 171 – 178 .
4.
4 Yau V Chow E Davis L Holden L Schueller T Danjoux C . Pain management in cancer patients with bone metastases remains a challenge . J Pain Symptom Manage2004; 27: 1 – 3 .
5.
5 McQuay HJ; Collins SL; Carroll D; Moore RA; . Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev 1999; Issue 3. Art. No.: CD001793. DOI: 10.1002/14651858.CD001793.
6.
6 Coluzzi PH Schwartzberg L Conroy JD Charapata S Gay M Busch MA . Breakthrough cancer pain: a randomized controlled trial comparing oral transmucosal fentanyl citrate and morphine sulphate immediate release . Pain2001; 91: 123 – 130 .
7.
7 Wong R; Wiffen PJ; . Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002; Issue 2. CD002068.
8.
8 Robb K; Bennett MI; Johnson MI; Simpson KH; Oxberry SG; . Transcutaneous Electrical Nerve Stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev 2008; Issue 3. CD006276.
9.
9 Urch CE Donovan-Rodriguez T Dickenson AH . Alterations in dorsal horn neurones in a rat model of cancer induced bone pain . Pain2003; 106: 347 – 356 .
10.
10 Rolke R Eich N Schwab R Jage J Weber M Treede R-D . Quantitative sensory testing: assessment of the neuropathic pain component in cancer pain . Eur J Pain2007; 11: S112 – S113 .